| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/12/2009 | US20090041848 Skin anti-aging agent for external use |
| 02/12/2009 | US20090041847 Photostabilizing electronic excited state energy particularly singlet state energy from UV-absorbing molecule has been found to be readily transferred to alpha-cyanodiphenylacrylate compounds having an alkoxy radical in four position on phenyl rings; increases UV absorbing life of sunscreen agent |
| 02/12/2009 | US20090041846 Minocycline oral dosage forms for the treatment of acne |
| 02/12/2009 | US20090041845 Implantable medical devices having thin absorbable coatings |
| 02/12/2009 | US20090041844 Modified Release Formulation |
| 02/12/2009 | US20090041843 Pharmaceutical preparation having excellent photostability |
| 02/12/2009 | US20090041842 Partly Neutralised Anionic (Meth) Acrylate Copolymer |
| 02/12/2009 | US20090041841 Controlled release tablet formulations for the prevention of arrhythmias |
| 02/12/2009 | US20090041840 Positive wakeup pharmaceutical sleep system with compatible pre-bedtime administration |
| 02/12/2009 | US20090041839 Pharmaceutical compositions for the treatment of pain |
| 02/12/2009 | US20090041838 Anti-Misuse Microparticulate Oral Drug Form |
| 02/12/2009 | US20090041837 Aptamers utilized as targeting agents for pharmaceutical compounds used in the treatment of cancer and other diseases |
| 02/12/2009 | US20090041836 Glycolipopeptide and uses thereof |
| 02/12/2009 | US20090041835 Method of inhibiting leakage of drug encapsulated in liposomes |
| 02/12/2009 | US20090041834 Compositions and methods for treating lymphoma |
| 02/12/2009 | US20090041833 Composition comprising gas-filled microcapsules for ultrasound mediated delivery |
| 02/12/2009 | US20090041832 Adhesive mixture for transdermal delivery of highly plasticizing drugs |
| 02/12/2009 | US20090041831 Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl |
| 02/12/2009 | US20090041830 Traumatic brain injury biomarker diagnostic |
| 02/12/2009 | US20090041829 Pharmaceutical dosage forms comprising a lipid phase |
| 02/12/2009 | US20090041828 Insert for the treatment of dry eye |
| 02/12/2009 | US20090041827 Therapeutic Microfoam |
| 02/12/2009 | US20090041820 Functional polymer compositions |
| 02/12/2009 | US20090041816 Coated particles |
| 02/12/2009 | US20090041815 Assembly comprising a substrate comprising biocellulose, and a powdered cosmetic composition to be brought into contact with the substrate |
| 02/12/2009 | US20090041813 Active substance composition comprising at least one nitrogen atom-containing, hyperbranched polymer |
| 02/12/2009 | US20090041811 Oil-In-Water Emulsion Composition |
| 02/12/2009 | US20090041810 Immunostimulating polyphosphazene compounds for intradermal immunization |
| 02/12/2009 | US20090041805 Locally administering botulinum toxin powder to a patient using a using a needleless syringe connected to a tank of compressed inert gas, such as helium, for producing a supersonic gas flow; gold, platinum, tungsten or ice crystal carrier; pain is alleviated within 1 to 7 days of administration |
| 02/12/2009 | US20090041759 Materials and methods for treating ocular-related disorders |
| 02/12/2009 | US20090041724 Protein Delivery System |
| 02/12/2009 | US20090041697 Film-Forming Compositions for Protecting Skin From Body Fluids and Articles Made Therefrom |
| 02/12/2009 | US20090041682 Medical product |
| 02/12/2009 | US20090041681 Anti-inflammatory inhalation pharmaceutical composition |
| 02/12/2009 | US20090041680 Wax Foamable Vehicle and Pharmaceutical Compositions Thereof |
| 02/12/2009 | US20090041679 Human neutralizing monoclonal antibodies to h5n1 influenza a virus |
| 02/12/2009 | US20090041678 Metronidazole-based dermatological foams and emulsions for the preparation thereof |
| 02/12/2009 | US20090041676 Targeted Delivery of Lidocaine and Other Local Anesthetics and A Method For Treatment of Cough, Asthma and Tussive Attacks |
| 02/12/2009 | US20090041675 Organic compounds |
| 02/12/2009 | US20090038612 Medical product containing tiotropium |
| 02/12/2009 | DE112007000920T5 Pharmazeutische Zusammensetzungen von Cefixim Pharmaceutical compositions of cefixime |
| 02/12/2009 | DE10064219B9 Neue Fentanyl und/oder dessen Derivate enthaltende pharmazeutische Zusammensetzung zur nasalen Anwendung New fentanyl and / or its derivatives containing pharmaceutical composition for nasal administration |
| 02/12/2009 | CA2707292A1 Powdered medicament for nasal delivery of ascorbic acid for reducing apomorphine induced toxicity to ciliated tissue |
| 02/12/2009 | CA2706828A1 Improvements relating to skin dressings |
| 02/12/2009 | CA2704929A1 Compositions and methods for procedural sedation and analgesia using oral transmucosal dosage forms |
| 02/12/2009 | CA2702711A1 Liquid preparation containing herb and/or animal-origin extract |
| 02/12/2009 | CA2700733A1 Bupropion hydrobromide and therapeutic applications |
| 02/12/2009 | CA2695991A1 Immunoliposome inducing apoptosis into cell expressing death domain-containing receptor |
| 02/12/2009 | CA2695901A1 Nucleic acid-lipopolymer compositions |
| 02/12/2009 | CA2695731A1 Microneedle arrays formed from polymer films |
| 02/12/2009 | CA2695697A1 Protein formulations comprising gdf-5 in aqueous acidic solution |
| 02/12/2009 | CA2695366A1 Nutritional supplement system |
| 02/12/2009 | CA2695294A1 Use of a material based on a thermoplastic polymer having a high content of antioxidants for packaging dianhydrohexitols |
| 02/12/2009 | CA2694622A1 Improvements relating to skin dressings |
| 02/12/2009 | CA2694061A1 Gel composition for external application containing an adenine compound |
| 02/12/2009 | CA2692837A1 Use of eflucimibe for the production of a medicament for the prevention or treatment of a disease caused by sebaceous gland dysfunction in humans or animals |
| 02/11/2009 | EP2022853A1 Freeze-dried product for transferring nucleic acid, oligonucleic acid or derivative thereof |
| 02/11/2009 | EP2022557A1 A process for the preparation of granular frozen powder |
| 02/11/2009 | EP2022504A1 Ointment for the treatment of haemorrhoids |
| 02/11/2009 | EP2022503A1 Capsulated vaccine extracts with balanced intestinal release |
| 02/11/2009 | EP2022497A1 Oral composition comprising 3-[5-[4-(cyclopentyloxy) -2-hydroxybenzoyl]-2-](3-hydroxy-1,2-benzisoxazol-6- yl)methoxy¨phenyl¨propionic acid or salt thereof |
| 02/11/2009 | EP2022496A1 Stable ropinirole compositions |
| 02/11/2009 | EP2022494A2 Laxative preparation containing l-Arginine |
| 02/11/2009 | EP2021096A1 Use of tannins in filters |
| 02/11/2009 | EP2021035A2 Cell-matrix microspheres, methods for preparation and applications |
| 02/11/2009 | EP2021031A1 Hydrogel sheet and production method thereof |
| 02/11/2009 | EP2021030A2 Buffering agents for biopharmaceutical formulations |
| 02/11/2009 | EP2021002A2 Pharmaceutical composition |
| 02/11/2009 | EP2020995A2 Zero-order modified release solid dosage forms |
| 02/11/2009 | EP2020994A2 Sustained release pharmaceutical dosage form containing phenylephrine |
| 02/11/2009 | EP2020993A2 Solid pharmaceutical composition of gabapentin |
| 02/11/2009 | EP2020992A2 Method of producing immunoliposomes and compositions thereof |
| 02/11/2009 | EP2020991A2 A direct cellular energy delivery system |
| 02/11/2009 | EP2020990A2 Two-piece, internal-channel osmotic delivery system flow modulator |
| 02/11/2009 | EP2020989A2 Pulmonary delivery of 1,25-dihydroxyvitamin d3 and co-administration of parathyroid hormone or calcitonin |
| 02/11/2009 | EP2020988A2 Compositions comprising fusogenic proteins or polypeptides derived from prosaposin for application in transmembrane drug delivery systems |
| 02/11/2009 | EP2020987A1 Sol-gel nanostructured titania reservoirs for use in the controlled release of drugs in the central nervous system and method of synthesis |
| 02/11/2009 | EP2020849A2 Preparation and utility of substituted carboxylic acid compounds |
| 02/11/2009 | EP1937221B1 Retard formulation for pralnacasan |
| 02/11/2009 | EP1888223B1 Method and device for encapsulating materials in liposomes comprising a freely adaptable membrane structure |
| 02/11/2009 | EP1796646B1 Cosmetic neurotoxin compositions comprising a botulinum toxin component and methods |
| 02/11/2009 | EP1663168B1 Nicotine formulations and use thereof |
| 02/11/2009 | EP1622601B1 Pharmaceutical compositions |
| 02/11/2009 | EP1581236A4 Sustained release of antiinfectives |
| 02/11/2009 | EP1480687B1 Modified phosphocalcic compound, injectable composition containing same |
| 02/11/2009 | EP0954286B1 Liposomal influenza vaccine composition and method |
| 02/11/2009 | CN201192758Y Laser boring system apparatus of controlled-release pharmaceutical tablet |
| 02/11/2009 | CN201192757Y Laser boring system apparatus of controlled-release pharmaceutical tablet |
| 02/11/2009 | CN201192473Y Medicine paste for treating tracheitis |
| 02/11/2009 | CN201192472Y Acupuncture point plaster |
| 02/11/2009 | CN201192471Y Anus bolt |
| 02/11/2009 | CN101365671A Isohumulone compound clathrate and composition containing the same |
| 02/11/2009 | CN101365512A Bisphosphonate formulation |
| 02/11/2009 | CN101365491A Particulate lipid pharmaceutical composition |
| 02/11/2009 | CN101365456A Method for treating primary and secondary forms of glaucoma |
| 02/11/2009 | CN101365453A Dipyridamole extended-release formulations and process for preparing same |
| 02/11/2009 | CN101365450A Stable pharmaceutical formulations of montelukast sodium |
| 02/11/2009 | CN101365449A Nanoparticulate benzothiophene formulations |
| 02/11/2009 | CN101365433A Iontophoresis preparation |
| 02/11/2009 | CN101365429A Sealed tablet |